Brugada Syndrome Test Test code: 02212 • 10–21 days turnaround time Up to 20 genes
Brugada Syndrome Panel
This panel is intended for individuals with a clinical diagnosis or suspected diagnosis of Brugada syndrome. It evaluates genes associated with Brugada syndrome as well as genes linked to other inherited cardiac arrhythmia disorders that may present with similar clinical features.
Because inherited arrhythmia conditions can have overlapping symptoms and clinical findings, genetic testing may help identify an underlying genetic cause and provide information to support appropriate medical management.
Individuals with clinical symptoms or findings suggestive of Brugada syndrome may benefit from diagnostic genetic testing to:
- Establish or confirm a clinical diagnosis
- Identify an inherited genetic cause
- Clarify potential cardiac and arrhythmia risks
- Guide individualized medical management
- Support appropriate cardiac monitoring and risk-reduction strategies
- Inform genetic counseling and family testing
Family Testing:
Asymptomatic family members of an individual with a known pathogenic variant may also benefit from targeted genetic testing. Identifying whether a family member carries the familial variant may help clarify their personal risk and support appropriate clinical evaluation and management.
Genetic information may also help individuals and their healthcare professionals make informed decisions regarding activities, medications, and other potential triggers that could increase the risk of symptoms or abnormal heart rhythms.
Important: Activity and medication decisions should always be made in consultation with a qualified healthcare professional and should be based on the individual's genetic results, clinical history, family history, and overall cardiac evaluation.